Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Satellos Bioscience Inc.
Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders
May 14, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights
May 14, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 08, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
March 27, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos to Present at Upcoming Virtual Investor Conferences in March and April
March 14, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos to Participate in the Leerink Partners Global Biopharma Conference 2024
March 05, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos Presents Positive Preclinical Efficacy Data for SAT-3247 at the 2024 MDA Clinical & Scientific Conference
March 04, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos Recognized as a Top 50 TSX Venture Exchange Company
February 21, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
TSX:MSCL
Satellos Announces Upcoming Presentations at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
February 20, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos to Commence Trading on the Toronto Stock Exchange
February 14, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX:MSCL
Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy
February 13, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX-V:MSCL
Satellos Receives Conditional Approval to Graduate to the Toronto Stock Exchange
January 16, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX-V:MSCL
Satellos Bioscience Announces 2023 Q3 Financial Results and Operational Highlights
November 22, 2023
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
TSX-V:MSCL
Satellos to Present at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX-V:MSCL
Satellos Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program
November 14, 2023
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX-V:MSCL
Satellos to Present at the Stifel 2023 Healthcare Conference
November 02, 2023
From
Satellos Bioscience Inc.
Via
Business Wire
Tickers
MSCLF
TSX-V:MSCL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.